Durham, NC, United States of America

Barry Riddle Sickles

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2000-2015

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Barry Riddle Sickles

Introduction

Barry Riddle Sickles is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of 5 patents, Sickles has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents are the crystalline forms of an antiviral benzimidazole compound. This invention relates to crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole. The patent also covers pharmaceutical compositions comprising the same, processes for preparing the same, and their use in medical therapy. This work highlights his commitment to advancing medical treatments through innovative chemical formulations.

Career Highlights

Barry Sickles has had a distinguished career, working with prominent companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has allowed him to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Sickles has collaborated with talented individuals, including Bobby Neal Glover and Lian-Feng Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Barry Riddle Sickles is a prominent inventor whose work in antiviral compounds has made a lasting impact on the pharmaceutical industry. His patents and collaborations reflect his dedication to improving medical therapies and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…